ZimVie — Q3 2023 Earnings Presentation
10 slides from ZimVie's earnings presentation, Nov 1, 2023
Slide 1: Supplemental Financial Information
Supplemental Financial Information November 1, 2023 Exhibit 99.2
Slide 2: Forward-Looking Statements and Non-GAAP Measures
FORWARD-LOOKING STATEMENTS AND NON-GAAP MEASURES Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 This presentation contains forward-looking statements within the meaning of federal securities laws, including, among others, any statements about our expectations, plans
Slide 3: 3Q 2023 Results
3Q 2023 Results 12.7% Adjusted EBITDA Margin[1] $0.08 Adjusted Diluted EPS[1] Third Party Net Sales: $202.9M Adjusted EBITDA[1]: $25.8M Adjusted Net Income[1]: $2.2M [1] This is a Non-GAAP financial measure. Refer to the reconciliation in the Appendix for further information. $105.3M in Dental Third
Slide 4: 2023 Full-Year Financial Guidance
2023 Full-Year Financial Guidance Line Item 2023 Guidance Net Sales* $860M - $870M Adjusted cost of products sold, excluding intangible asset amortization[1] Low-to-mid 30%s Adjusted EBITDA Margin[1] 13.5% - 14.0% Interest Expense $37M - $38M Stock-Based Compensation[1][2] $16.5M - $18.5M Adjusted E
Slide 5: Appendix
Bendix 2 ZimVie
Slide 6: Note on Non-GAAP Financial Measures
Note on Non-GAAP Financial Measures This presentation includes non-GAAP financial measures that differ from financial measures calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These non-GAAP financial measures may not be comparable to similar measures reported by
Slide 7: Net Sales by Region and Segment
ZimVie NET SALES BY REGION AND SEGMENT (in thousands) [1] United States sales include Puerto Rico.
Slide 8: Reconciliation of Adjusted EBITDA
ZimVie RECONCILIATION OF ADJUSTED EBITDA (in thousands) [1] In April 2023, we instituted restructuring activities to better position our organization for future success based on the current business environment, and in July 2023, we continued these activities and took additional actions. The expense
Slide 9: Reconciliation of Adjusted COS, R&D and SG&A
ZimVie RECONCILIATION OF ADJUSTED COS, R&D AND SG&A (in thousands) [1] The 2023 amounts represent inventory write-offs resulting from restructuring activities and property, plant, and equipment step-up amortization from prior acquisitions. The 2022 amounts represent expenses captured through allocat
Slide 10: Reconciliation of Adjusted Net Income (Loss) and Adjusted EPS
ZimVie RECONCILIATION OF ADJUSTED NET INCOME (LOSS) AND ADJUSTED EPS (in thousands, except per share data) [1] In April 2023, we instituted restructuring activities to better position our organization for future success based on the current business environment, and in July 2023, we continued these